Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




HALT-C Trial Gets Negative Results
Link ID 678
Title HALT-C Trial Gets Negative Results
Url http://www.medscape.com/viewarticle/565457?src=rss
Description Maintenance therapy with peginterferon failed to halt liver disease progression in patients infected with hepatitis C virus. Medscape Medical News
Category Articles > Gastroenterology
Keywords
Date Nov 12, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Gastroenterology
1. Studies Confirm Link Between Serrated Polyps, Colorectal Cancer
  Large or proximal serrated polyps are associated with an increased risk of neoplasia and colorectal cancer (CRC), and their presence should trigger more frequent surveillance, according to two studies published online in the November Gastroenterology. Reuters Health Information
Category:   Articles > Gastroenterology


2. Elevated AST, ALT Linked to Higher Future Mortality Rate
  Elevated liver enzymes discovered during routine medical care are associated with increased mortality risk over the subsequent decade, results of a study published in the March issue of Hepatology indicate. Reuters Health Information
Category:   Articles > Gastroenterology


3. Colonoscopy and Colorectal Cancer Prevention
  Douglas K. Rex, MD, FACG, reviews the latest trends and recommendations regarding screening and surveillance in colorectal cancer, as based on data presented at ACG 2007.
Medscape Gastroenterology
Category:   Articles > Gastroenterology


4. Elevated NGAL Associated With Severe Vs. Mild Acute Pancreatitis
  Elevated levels of serum neutrophil gelatinase-associated lipocalin (NGAL) could be a marker of severe acute pancreatitis and poor outcomes, a pilot study suggests. Reuters Health Information
Category:   Articles > Gastroenterology


5. The Ethics of Phase I Trials of Biologic Agents
  Early and limited exposure to biologics can cause antibodies to develop and, ultimately, prevent trial participants from gaining any treatment benefit. In this editorial, the author calls for the risks to be clearly stated.
Nature Clinical Practice Gastroenterology & Hepatology
Category:   Articles > Gastroenterology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS